Clinical trial
Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis
NCT00267852 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00267852 |
|---|---|
| Title | Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis |
| Official title | An Observational Study To Evaluate The Clinical Remission In Early Aggressive Rheumatoid Arthritis (Artrite Reumatoide Precoce Aggressiva Italian Study) |
| Acronym | ARPA |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Other |
| Interventions | as clinical practice |
| Enrollment | 152 |
| Start date | Apr 1, 2006 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Dec 21, 2005 |
| Last update posted | Sep 15, 2011 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: